CDK8/19-IN-51 is an orally active and highly effective dual inhibitor of CDK8 and CDK19, with anticancer activity. Its IC50 values for CDK8 and CDK19 are 5.1 nM and 5.6 nM, respectively. It is used in studies of colorectal and gastric cancers.
Molekulargewicht:
414.46
Reinheit:
98.65%
CAS Nummer:
[1860885-61-5]
Formel:
C23H22N6O2
Target-Kategorie:
CDK
T22633
T22633
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten